Nuclear glucocorticoid binding in chronic lymphatic leukemia lymphocytes

Area of Science:

• Endocrinology
• Hematology
• Molecular Biology

Background:

• Chronic lymphatic leukemia (CLL) is a hematologic malignancy characterized by the accumulation of abnormal lymphocytes.
• Glucocorticoid receptors play a role in cellular function and are potential therapeutic targets.

Purpose of the Study:

• To establish a reliable method for isolating 3H-triamcinolone acetonide (3H-TA) receptor complexes from chronic lymphatic leukemia (CLL) lymphocyte nuclei.
• To assess specific nuclear glucocorticoid binding in patients with untreated CLL.

Main Methods:

• Developed a procedure using carbobenzoxy-L-phenylalanine (CBZ-L-phe) to stabilize hormone-receptor complexes during nuclear extraction with 0.6M KCl.
• Isolated and quantified 3H-TA receptor complexes from purified CLL lymphocyte nuclei.

Main Results:

• Successfully demonstrated a reliable method for isolating 3H-TA receptor complexes.
• Confirmed specific nuclear glucocorticoid binding in all 14 patients with untreated CLL.
• Found no correlation between nuclear-associated 3H-TA levels and peripheral white blood cell count or lymphocyte rosetting ability.

Conclusions:

• The described method provides a reliable means to study nuclear glucocorticoid receptor binding in CLL.
• Specific nuclear glucocorticoid binding is consistently present in untreated CLL patients.
• Nuclear-associated 3H-TA levels do not correlate with disease burden indicators like white blood cell count.